Welcome to BioMarket Group!

    • The product Website Benchmarking Tool: US and European Targeted Websites has been added to comparison list.

Website Benchmarking Tool: US and European Targeted Websites

Additional Information

Published Date Dec 26, 2005
Special Offer No
Pages No
PDF Fact Sheet View Fact Sheet for the report Website Benchmarking Tool: US and European Targeted Websites in PDF format.
Published on Date No
Format Interactive Model
Publisher Datamonitor
Product Line No
Full Title No

Availability: In stock

$22,800.00

Quick Overview

Many prescribers rely on websites provided by pharmaceutical companies when searching for treatment information. Consumers also rely heavily on online resources when searching for disease and treatment information. Websites that tailor their site content to address the specific needs of their target audience will experience greater retention of site visitors.
Request free sample pages from Website Benchmarking Tool: US and European Targeted Websites

Introduction

Many prescribers rely on websites provided by pharmaceutical companies when searching for treatment information. Consumers also rely heavily on online resources when searching for disease and treatment information. Websites that tailor their site content to address the specific needs of their target audience will experience greater retention of site visitors.

Scope

    Highlights

    Reasons to Purchase

    • Assess and compare the value of leading global pharmaceutical companies’ online presence across a number of criteria
    • Identify which tools and services are being used to encourage consumers and healthcare professionals to frequently revisit a website
    • Compare the websites of products in the same class to see what gives the leaders a competitive edge

Request free sample pages from Website Benchmarking Tool: US and European Targeted Websites

Other selected research from the 'Europe' category:


Pharma Market Authorization Strategies: A guide to launching drugs quickly and efficiently in Europe
This report is a comprehensive source of market analysis of the most valuable therapy area within the global pharmaceutical market; Valued at an estimated $73.7bn in 2002, the global market for cardiovascular drugs grew by a moderate 2.5% over 2001 levels Learn More


European Biotech Industry Guide 2007, 5th Ed.
This exciting intelligence CD-ROM on European biotech industry has become better, stronger and more intelligent in its 5th Edition. Learn More

Other selected research from the 'USA' category:


US Diabetes Market Analysis
Our study indicates that health spending associated with diabetes and pre-diabetes was about US$ 194 Billion in 2010 (approximately 7% of total U.S. health spending). Learn More


US Pharmaceutical Market Outlook 2011-2021
we show you where the largest pharma market is heading
Do you want to know the effects of the Obama government’s legislation for US healthcare? Insurance coverage will be extended...
Learn More

Other selected research from the 'IT & eHealth' category:


Healthcare Technology Telehealths Increasing Role in Healthcare (Review Report)
An in-depth analysis of the telehealth market including vendor strategies and end-user technology requirements. Learn More


Remote & Wireless Patient Monitoring Markets
Patient monitoring systems are emerging in response to increased healthcare needs of an aging population, new wireless technologies, better video and monitoring technologies, decreasing healthcare resources, an emphasis on reducing... Learn More

Other selected research from the 'Pharmacoeconomics' category:


Optimizing Sales Force Effectiveness: Using eHealth Applications to Improve the Quality of Physician Interactions
Gaining access to influential healthcare professionals is difficult because physicians often do not have time to see drug reps during the working day. Furthermore, drug reps often fail to make the most of the limited time they do have with prescribers. Over time this has caused drug reps to lose influence to patient requests during the prescribing process. Learn More


The eHealth Market in the US: Assessing the Online Needs of Physicians and Consumers
The eHealth market in the US is generally more developed than that in Europe. Substantial investment from the government and the pharmaceutical industry has propelled the developments in initiatives such as online continuing medical education. There appears to be significant potential for further uptake of online services, most notably in the areas of eDetailing, eSampling and online CME. Learn More